OPTH ▲ +2.0% - Optimi Health Corp. $OPTH - Optimi Health to Initiate Phase 2 Clinical Trial Evaluating Psilocybin-Assisted Therapy for Major Depressive Disorder Optimi Health rose 2.0% after announcing it will initiate a Phase 2 clinical trial evaluating psilocybin-assisted therapy for major depressive disorder. The advancement to Phase 2 represents a significant milestone in the company's pipeline development and suggests regulatory clearance to proceed with a larger patient study. 10-SEP-2026 08:45 AM ET